Followers | 190 |
Posts | 15125 |
Boards Moderated | 0 |
Alias Born | 08/26/2010 |

Thursday, May 18, 2023 10:36:30 AM
Volume: | 137,838 |
Day Range: | 1.11 - 1.27 |
Bid: | 1.15 |
Ask: | 1.32 |
Last Trade Time: | 7:40:16 PM EDT |
Total Trades: | 727 |
Recent ENVB News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/04/2025 09:17:58 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/02/2025 08:12:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2025 12:00:26 PM
- Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024 • Business Wire • 03/31/2025 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/28/2025 09:19:42 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/24/2025 09:25:45 PM
- Enveric Biosciences Participating in BIO-Europe Spring® • Business Wire • 03/17/2025 05:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2025 02:30:10 PM
- Enveric Biosciences CEO Issues Letter to Shareholders • Business Wire • 02/27/2025 02:30:00 PM
- This Biotech Soared On Key Announcement • AllPennyStocks.com • 02/26/2025 07:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2025 01:30:53 PM
- Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent • Business Wire • 02/25/2025 06:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/05/2025 10:15:51 PM
- Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease • Business Wire • 02/04/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/03/2025 10:30:25 PM
- Enveric Biosciences Announces Closing of $5 Million Public Offering • Business Wire • 02/03/2025 10:00:00 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/03/2025 11:24:35 AM
- Enveric Biosciences Announces Pricing of $5 Million Public Offering • Business Wire • 01/31/2025 01:14:00 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/30/2025 10:10:52 PM
- Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office • Business Wire • 01/30/2025 09:01:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/30/2025 01:01:24 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/27/2025 11:10:21 AM
Wytec Prepares for 1st AI Gunshot Detection Pilot • WYTC • Apr 4, 2025 7:09 AM
ConnectM Receives $1.60 Per Share Buyout Offer from its Three Largest Institutional Investors • CNTM • Apr 2, 2025 9:00 AM
Nightfood Holdings Completes Acquisition of Carryout Supplies, Deepening Vertical Integration in AI-Powered Hospitality Automation • NGTF • Apr 2, 2025 8:30 AM
Avant Technologies Partner, Ainnova, to Sponsor and Present at 2025 Healthcare Innovation Summit in Mexico City • AVAI • Apr 2, 2025 8:00 AM
Glidelogic Corp. Unveils ResearchMind - Pioneering AI-Driven Research Innovation for a Global Academic Community • GDLG • Apr 1, 2025 2:10 PM
Fifty 1 Labs, Inc. Celebrates Groundbreaking SpaceX, NASA, and ISS Yeast Experiment by Subsidiary Genetic Networks • FITY • Apr 1, 2025 9:30 AM